Anti-aging pill tested in 1-year human trial

NCT ID NCT06592859

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether taking a daily capsule of nicotinamide mononucleotide (NMN) can reduce biological age in healthy adults aged 40-70. Over 240 participants will take either NMN or a placebo for one year. Researchers will measure aging using blood tests and other markers to see if NMN can truly slow the aging process.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

nicotinamide mononucleotide (NMN) dietary supplement

What this could lead to

If it works, this could point toward a simple supplement to slow or reverse some signs of aging in healthy people.

What could go wrong

This is an early-stage study with only 240 participants, so results may not apply to everyone. NMN supplements are not regulated like drugs, and long-term safety is unknown.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • People's Hospital of Quzhou

    RECRUITING

    Quzhou, Zhejiang, 324000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact